Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1459 (28 June), doi:10.1136/bmj.326.7404.1459
| The first 150 words of the full text of this article appear below. |
EDITORChopdar et al searched Medline for literature but seem to have neglected over 75 publications on macular relocation surgery for age related and myopic macular degeneration.1 They concluded that no current treatment will restore vision that has already been lost.
The excitement over macular relocation is precisely because it is capable of improving vision in some patients despite moderate and severe visual loss.2 Lai et al reported that at six months, the reading vision was significantly improved, from 0.54 to 0.40 LogMAR units in a consecutive series of 15 patients (P=0.02).3 Pertile and Claes recently reported that in a consecutive series of 50 cases with a median follow up of 21 months 66% improved (2 or more lines), 28% remained stable (±1 line) and only 6% deteriorated (2 or more lines).4
Macular relocation surgery is complex and prone to complications including
proliferative vitreoretinopathy. As experience of this surgery
David Wong, consultant ophthalmic surgeon
St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool L7 8XP
David G Charteris, consultant ophthalmic surgeon
Vitreoretinal Surgical Unit david.charteris@moorfields.nhs.uk
Lyndon da Cruz, consultant ophthalmic surgeon
Medical and Surgical Retinal Units, Moorfields Eye Hospital, London EC1V 2PD